We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

177 hedge funds and large institutions have $375M invested in Antares Pharma, Inc. in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

589% more call options, than puts

Call options by funds: $868K | Put options by funds: $126K

189% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 9

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

23% more capital invested

Capital invested by funds: $305M → $375M (+$69.7M)

9% more funds holding

Funds holding: 162 → 177 (+15)

2% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 57

Holders
177
Holders Change
+15
Holders Change %
+9.26%
% of All Funds
2.79%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
26
Increased
56
Reduced
57
Closed
9
Calls
$868K
Puts
$126K
Net Calls
+$742K
Net Calls Change
+$401K

Top Buyers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
+$6.91M
2
VCIM
Velan Capital Investment Management
Georgia
+$4.89M
3
Amundi
Amundi
France
+$3.46M
4
SCM
Stonepine Capital Management
Oregon
+$3.02M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$2.85M

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$5.01M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.98M
3
BFM
Boothbay Fund Management
New York
-$757K
4
Barclays
Barclays
United Kingdom
-$674K
5
Deutsche Bank
Deutsche Bank
Germany
-$607K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.54M -$78.5K -21,652 -3%
State Board of Administration of Florida Retirement System
27
State Board of Administration of Florida Retirement System
Florida
$2.5M -$512K -141,235 -19%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$2.36M -$333K -91,800 -14%
LFCM
29
Long Focus Capital Management
Puerto Rico
$2.21M – – –
PCM
30
Perkins Capital Management
Minnesota
$1.97M +$16.3K +4,500 +0.9%
Millennium Management
31
Millennium Management
New York
$1.92M +$1.32M +362,862 +344%
Citadel Advisors
32
Citadel Advisors
Florida
$1.84M +$1.43M +395,190 +739%
Boston Partners
33
Boston Partners
Massachusetts
$1.73M +$884K +243,758 +138%
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.68M -$42.8K -11,803 -3%
Swiss National Bank
35
Swiss National Bank
Switzerland
$1.57M +$100K +27,700 +8%
MF
36
Magnetar Financial
Illinois
$1.54M -$5.01M -1,379,754 -79%
OAM
37
Oberweis Asset Management
Illinois
$1.41M +$337K +93,000 +37%
Ameriprise
38
Ameriprise
Minnesota
$1.29M +$23.4K +6,457 +2%
AC
39
Avenir Corporation
Virginia
$1.24M +$3.63K +1,000 +0.3%
Fidelity Investments
40
Fidelity Investments
Massachusetts
$1.2M -$1.98M -545,914 -65%
Marshall Wace
41
Marshall Wace
United Kingdom
$1.13M +$999K +275,284 New
William Blair & Company
42
William Blair & Company
Illinois
$1.13M – – –
AG
43
Algert Global
California
$1.1M +$458K +126,314 +89%
PPA
44
Parametric Portfolio Associates
Washington
$1.09M +$346K +95,334 +56%
First Trust Advisors
45
First Trust Advisors
Illinois
$1.07M -$54.9K -15,133 -5%
Baird Financial Group
46
Baird Financial Group
Wisconsin
$1.01M – – –
Invesco
47
Invesco
Georgia
$993K -$127K -35,078 -13%
CC
48
Clearline Capital
New York
$987K +$126K +34,600 +17%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$976K +$864K +238,233 New
Renaissance Technologies
50
Renaissance Technologies
New York
$899K +$796K +219,328 New
1
2
3 4 5

ATRS Hedge Fund Activity: Q1 2022 in Review

177 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q1 2022, worth a combined $375M — up 23% from $305M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ATRS positions and 9 closed out — a net gain of 17 holders — while 56 added to existing stakes and 57 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $6.91M. The largest seller was Magnetar Financial, cutting an estimated $5.01M.

  • 177 institutional investors held Antares Pharma, Inc. (ATRS) as of Q1 2022, up from 162 in Q4 2021.
  • Funds reported $375M of Antares Pharma, Inc. stock for Q1 2022, up 23% quarter-over-quarter.
  • 26 funds opened new Antares Pharma, Inc. positions in Q1 2022 and 9 closed out, a net change of +17 holders.
  • The largest Antares Pharma, Inc. buyer in Q1 2022 was Russell Investments Group, an estimated $6.91M added.
  • The largest Antares Pharma, Inc. seller in Q1 2022 was Magnetar Financial, an estimated $5.01M sold.

Based on aggregated 13F filings for Q1 2022.